AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ANXA1 |
P04083
|
annexin A1
|
|
1.2E-07 |
0.442 |
0.885 |
APOBEC3A |
P31941
|
apolipoprotein B mRNA editing enzyme catalytic subunit 3A
|
|
1.0E-03 |
0.612 |
0.692 |
ARID1A |
O14497
|
AT-rich interaction domain 1A
|
|
1.00 |
0.455 |
0.846 |
ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
CSN1S1 |
P47710
|
casein alpha s1
|
Storage
|
1.4E-16 |
0.780 |
0.346 |
CD109 |
Q6YHK3
|
CD109 molecule
|
|
2.3E-44 |
0.595 |
0.654 |
CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
CD82 |
P27701
|
CD82 molecule
|
|
1.3E-08 |
0.507 |
0.731 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |
FSD1 |
Q9BTV5
|
fibronectin type III and SPRY domain containing 1
|
|
0.25 |
0.486 |
0.808 |
FSD1L |
Q9BXM9
|
fibronectin type III and SPRY domain containing 1 like
|
|
0.23 |
0.488 |
0.808 |
FHIT |
P49789
|
fragile histidine triad diadenosine triphosphatase
|
|
5.7E-03 |
0.444 |
0.846 |
GPS1 |
Q13098
|
G protein pathway suppressor 1
|
|
1.00 |
0.769 |
0.346 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
HDGF |
P51858
|
heparin binding growth factor
|
Signaling
|
0.27 |
0.575 |
0.654 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
IGF1R |
P08069
|
insulin like growth factor 1 receptor
|
Kinase
|
0.97 |
0.399 |
0.885 |
IGFBP2 |
P18065
|
insulin like growth factor binding protein 2
|
Enzyme modulator
|
0.12 |
0.478 |
0.769 |